Skip to content
2000
Volume 29, Issue 13
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Background: The carboxylic acid moiety is an important functional group which features in the pharmacophore of some 450 drugs. Unfortunately, some carboxylic acid-containing drugs have been withdrawn from market due to unforeseen toxicity issues. Other issues associated with the carboxylate moiety include reduced metabolic stability or limited passive diffusion across biological membranes. Medicinal chemists often turn to bioisosteres to circumvent such obstacles. Objective: The aim of this review is to provide a summary of the various applications of novel carboxylic acid bioisosteres which have appeared in the literature since 2013. Results: We have summarised the most recent developments in carboxylic acid bioisosterism. In particular, we focus on the changes in bioactivity, selectivity or physicochemical properties brought about by these substitutions, as well as the advantages and disadvantages of each isostere. Conclusion: The topics discussed herein highlight the continued interest in carboxylate bioisosteres. The development of novel carboxylic acid substitutes which display improved pharmacological profiles is a testament to the innovation and creativity required to overcome the challenges faced in modern drug design.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867328666210820112126
2022-04-01
2024-12-24
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867328666210820112126
Loading

  • Article Type:
    Review Article
Keyword(s): acidity; bioisosterism; carboxylic acids; drug design; Isosteres; lipophilicity
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test